Replies to post #339518 on Amarin Corp Plc (AMRN)

[hamkypamky]

Intact from the start or reversed by SC (burning thru some years of exclusivity after ding donging thru the legal system)?

Before: $4B probably ($2b x 2 peak sales)
Now: $1.5-2B max even if reversed

Don't forget a few things:

1. Even if reversed we burn thru years of exclusivity
2. With reversal we still need to resolve the insurance PA requirement issue
3. Even assuming we resolve 1) and 2) by end 2022 (amazing timeline really) AMRN had proven itself incapable of growing sales exponentially and the ramp up will be less steep than many expect

In the hands of BP (and here I agree with CBB), Vascepa would be worth 2X my valuation, easily.